Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C2CD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MMD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARID4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2J1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUS4L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZC3H13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
BTBD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPRG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP152 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C5orf22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPY19L2P2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENDOD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPA2B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAPD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF609 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
REV3L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP250 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SP100 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on